ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Prediction of anti-vascular endothelial growth factor agent-specific treatment outcomes in neovascular age-related macular degeneration using a generative adversarial network

Moon, Sehwan; Lee, Youngsuk; Hwang, Jeongyoung; Kim, Chul Gu; Kim, Jong Woo; Yoon, Won Tae*; Kim, Jae Hui*
Scientific Reports2023-4-6DOI: 10.1038/s41598-023-32398-7
12被引2阅读
引用收藏
分享

摘要

To develop an artificial intelligence (AI) model that predicts anti-vascular endothelial growth factor (VEGF) agent-specific anatomical treatment outcomes in neovascular age-related macular degeneration (AMD), thereby assisting clinicians in selecting the most suitable anti-VEGF agent for each patient. This retrospective study included patients diagnosed with neovascular AMD who received three loading injections of either ranibizumab or aflibercept. Training was performed using optical coherence tomography (OCT) images with an attention generative adversarial network (GAN) model. To test the performance of the AI model, the sensitivity and specificity to predict the presence of retinal fluid after treatment were calculated for the AI model, an experienced (Examiner 1), and a less experienced (Examiner 2) human examiners. A total of 1684 OCT images from 842 patients (419 treated with ranibizumab and 423 treated with aflibercept) were used as the training set. Testing was performed using images from 98 patients. In patients treated with ranibizumab, the sensitivity and specificity, respectively, were 0.615 and 0.667 for the AI model, 0.385 and 0.861 for Examiner 1, and 0.231 and 0.806 for Examiner 2. In patients treated with aflibercept, the sensitivity and specificity, respectively, were 0.857 and 0.881 for the AI model, 0.429 and 0.976 for Examiner 1, and 0.429 and 0.857 for Examiner 2. In 18.5% of cases, the fluid status of synthetic posttreatment images differed between ranibizumab and aflibercept. The AI model using GAN might predict anti-VEGF agent-specific short-term treatment outcomes with relatively higher sensitivity than human examiners. Additionally, there was a difference in the efficacy in fluid resolution between the anti-VEGF agents. These results suggest the potential of AI in personalized medicine for patients with neovascular AMD.

学科与关键词

关键词
INTRAVITREAL AFLIBERCEPTARTIFICIAL-INTELLIGENCERETINAL FLUIDRANIBIZUMABBIOMARKERSIMPACT
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Scientific Reports
发表日期
2023-04-06
卷期
第 13 卷, 第 1 期
页码
5639
DOI
10.1038/s41598-023-32398-7
语言
ENGLISH
成果收录
SCIE
资助标注
Kim's Eye Hospital Research Center

作者

  • M

    Moon, Sehwan (第一作者)

  • L

    Lee, Youngsuk

查看全部 7 位作者收起作者
  • H

    Hwang, Jeongyoung

  • K

    Kim, Chul Gu

  • K

    Kim, Jong Woo

  • Y

    Yoon, Won Tae (通讯)

  • K

    Kim, Jae Hui (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417